ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,174Medicare Part D Prescriptions Filled, Including Refills

Rank: 871 out of 3647

$642K Total Retail Price of All Prescriptions

Rank: 670 out of 3647

574 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 574 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 574 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 8,008 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 414 351 1 5
AMLODIPINE BESYLATE 335 267 2 2
HYDROCODONE-ACETAMINOPHEN 306 211 S3 3 12
FUROSEMIDE 266 218 4 8
TRAMADOL HCL 261 210 5 22
LISINOPRIL 241 220 6 4
WARFARIN SODIUM 240 211 7 15
SIMVASTATIN 231 173 8 1
PANTOPRAZOLE SODIUM 221 180 9 38
METOPROLOL TARTRATE 207 172 10 7
CARVEDILOL 179 152 11 20
ZOLPIDEM TARTRATE 168 131 12 14
OMEPRAZOLE 167 141 13 3
HYDRALAZINE HCL 159 142 14 81
PRAVASTATIN SODIUM 148 121 15 16
ATORVASTATIN CALCIUM 147 111 16 13
GLYBURIDE 145 111 R 17 54
CLOPIDOGREL 122 103 18 26
GABAPENTIN 121 94 19 17
LOSARTAN POTASSIUM 118 94 20 11
DONEPEZIL HCL 102 102 21 30
CRESTOR 102 79 21 19
POTASSIUM CHLORIDE 95 76 23 24
SPIRONOLACTONE 91 85 24 77
SPIRIVA 82 73 25 93
METFORMIN HCL 81 56 26 6
DOXYCYCLINE HYCLATE 78 56 27 145
ISOSORBIDE MONONITRATE ER 77 67 28 56
PLAVIX 76 58 29 39
CIPROFLOXACIN HCL 76 59 29 53
CLONIDINE HCL 75 54 31 46
DIGOXIN 74 66 32 51
METOPROLOL SUCCINATE 73 55 33 18
DIOVAN 71 64 34 40
AZITHROMYCIN 70 56 35 34
LYRICA 67 33 36 120
GLIPIZIDE 64 43 37 41
PREDNISONE 63 36 38 43
TAMSULOSIN HCL 62 48 39 28
ALENDRONATE SODIUM 62 24 39 23
NEXIUM 61 37 41 44
AVELOX 61 53 41 448
FENTANYL 61 42 S2 41 147
HYDROCHLOROTHIAZIDE 60 55 44 9
ESCITALOPRAM OXALATE 57 55 45 65
ATENOLOL 55 48 46 10
CITALOPRAM HBR 54 38 47 25
COLCRYS 53 44 48 313
LANTUS 51 37 49 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 3, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.